Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Results of Operations
WST logo

West Pharma Boosts Q3 Sales 7.7% on Biologics Demand

WST10-QFiling Date: 10/23/2025
West Pharmaceutical Services Inc
Description

What this story covers

West Pharmaceutical Services reported Q3 net sales of $804.6M, up 7.7%, driven by Proprietary Products growth in biologics packaging. Nine-month sales rose 5.8%, with strong cash flow at $503.7M and stable debt. Strategy emphasizes innovation amid currency and supply risks, positioning for pharma trends.

Story snapshot

CompanyWest Pharmaceutical Services Inc
TickerWST
VariantStandard detailed
Duration9:58
Filing type10-Q
PeriodQ3 2025
IndustryHealthcare & Pharmaceuticals
Accession0000105770-25-000093

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in